Showing results (1291-1300 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|April 5, 2001
Food does not influence the pharmacokinetics of a new extended release formulation of tolterodine for once daily treatment of patients with overactive bladderB Olsson, J SzamosiClinical Pharmacokinetics|January 5, 2001
Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthmaC Falcoz, J Horton, A E Mackie, et al.Clinical Pharmacokinetics|August 5, 2000
Pharmacokinetics of quinupristin/ dalfopristin in patients with severe chronic renal insufficiencyP Chevalier, J Rey, O Pasquier, et al.Clinical Pharmacokinetics|August 21, 2001
Drug interaction studies with esomeprazole, the (S)-isomer of omeprazoleT Andersson, M Hassan-Alin, G Hasselgren, et al.Clinical Pharmacokinetics|August 21, 2001
Pegylation: a novel process for modifying pharmacokineticsJ M Harris, N E Martin, M ModiClinical Pharmacokinetics|October 19, 2001
The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatmentsN G Schneider, R E Olmstead, M A Franzon, et al.Clinical Pharmacokinetics|May 23, 2001
Pharmacokinetics and tolerability of the orally active selective epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in healthy volunteersH Swaisland, A Laight, L Stafford, et al.Clinical Pharmacokinetics|November 9, 2000
Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapyF Thalhammer, W H HörlClinical Pharmacokinetics|November 9, 2000
Nevirapine: pharmacokinetic considerations in children and pregnant womenM Mirochnick, D F Clarke, A DorenbaumClinical Pharmacokinetics|November 21, 2019
Midazolam Pharmacokinetics in Obese and Non-obese Children and AdolescentsChristina Gade, Eva Sverrisdóttir, Kim Dalhoff, et al.Pageof 348